Endocrinology Service

Congenital Adrenal Hyperplasia (CAH)

Congenital adrenal hyperplasia is a group of inherited conditions in which the adrenal glands can't make cortisol normally. The body compensates by overproducing androgens, and in some forms it also loses the ability to hold onto salt. CAH is lifelong — but with the right hormone replacement and monitoring, people with CAH grow, work, and have families like anyone else.

Congenital Adrenal Hyperplasia (CAH)

Classic and non-classic CAH

More than nine out of ten cases are caused by a deficiency of the enzyme 21-hydroxylase, inherited in an autosomal recessive pattern. How much enzyme activity remains determines which form a person has.

  • Classic, salt-wastingThe most severe form. Usually identified on newborn screening because of adrenal crisis risk in the first weeks of life.
  • Classic, simple virilizingCortisol is low and androgens are high, but salt balance is preserved.
  • Non-classic (late-onset)Much more common and often missed. Frequently first diagnosed in adolescence or adulthood.

Signs that bring adults to us

Non-classic CAH is regularly mistaken for PCOS. If you've been treated for irregular cycles or unwanted hair growth without a clear answer, it's worth a proper adrenal work-up.

  • Irregular or absent periods
  • Excess hair growth (hirsutism) and persistent acne
  • Scalp hair thinning
  • Difficulty conceiving
  • Early puberty or rapid early growth with a shorter final adult height
  • Fatigue, low blood pressure, or salt craving

How we diagnose CAH

Timing matters for these labs — 17-hydroxyprogesterone should be drawn early in the morning, and in menstruating patients during the follicular phase. We handle the sequencing so results are interpretable the first time.

  • Morning 17-hydroxyprogesteroneThe primary screening test for 21-hydroxylase deficiency.
  • ACTH (cosyntropin) stimulation testConfirms the diagnosis when baseline values are borderline.
  • Full adrenal and androgen panelCortisol, ACTH, renin, electrolytes, testosterone, DHEAS and androstenedione.
  • CYP21A2 genetic testingConfirms the diagnosis and informs family planning and carrier counseling.

Treatment and long-term management

The goal is to replace what the adrenal glands cannot make while using the lowest effective dose — enough to control androgen excess, not so much that patients carry the weight, bone and metabolic costs of over-replacement. That balance is the whole art of managing CAH, and it changes with age, pregnancy and illness.

  • Glucocorticoid replacementHydrocortisone, prednisone or dexamethasone, dosed and timed to the individual.
  • Mineralocorticoid replacementFludrocortisone, with salt supplementation, for salt-wasting CAH.
  • Crinecerfont (Crenessity)A newer non-steroidal option that lowers ACTH drive and can allow glucocorticoid doses to be reduced in eligible patients.
  • Sick-day and stress dosingA written plan, an emergency injectable hydrocortisone kit, and medical alert identification.
  • Fertility and pregnancy careCycle regulation, ovulation support, and co-management through pregnancy.
  • Ongoing monitoringGrowth and bone density, blood pressure, metabolic labs and adrenal hormone levels.

Transitioning from pediatric to adult care

Many people with classic CAH are diagnosed as infants and followed by a pediatric endocrinologist for two decades. The handoff to adult care is where patients most often fall out of follow-up — and where adrenal crises happen. We take that transition seriously and build a plan you can actually keep up with as an adult.